Chamberland Robin R
Department of Pathology, Saint Louis University School of Medicine, St. Louis, Missouri, USA
J Clin Microbiol. 2016 Oct;54(10):2431-5. doi: 10.1128/JCM.00144-16. Epub 2016 May 4.
Over 1 million men undergo biopsy in the United States each year to evaluate for prostate cancer (S. Loeb, H. B. Carter, S. I. Berndt, W. Ricker, and E. M. Schaeffer, J Urol 186:1830-1834, 2011, http://dx.doi.org/10.1016/j.juro.2011.06.057). In recent years, there has been a rise in infectious complications related to these procedures. This review aims to provide an overview of the guidelines that direct transrectal prostate biopsy, to describe associated infection, and to evaluate the published data driving the current trend toward prebiopsy screening for resistant organisms.
在美国,每年有超过100万男性接受活检以评估前列腺癌(S. Loeb、H. B. Carter、S. I. Berndt、W. Ricker和E. M. Schaeffer,《泌尿外科杂志》186:1830 - 1834,2011,http://dx.doi.org/10.1016/j.juro.2011.06.057)。近年来,与这些操作相关的感染并发症有所增加。本综述旨在概述指导经直肠前列腺活检的指南,描述相关感染,并评估推动目前活检前筛查耐药菌趋势的已发表数据。